Brief: Centric Health Qtrly Loss Per Share $0.10
Aug 14 (Reuters) - Centric Health Corp CHH.TO :
* CENTRIC HEALTH REPORTS Q2'18 FINANCIAL RESULTS, ANNOUNCES
NEW
STRATEGIC DIRECTION
* Q2 REVENUE ROSE 1 PERCENT TO C$43.3 MILLION
* QTRLY ADJUSTED EBITDA FROM CONTINUING OPERATIONS DECLINED
30% TO
$3.4 MILLION
* APPOINTMENT OF DAVID MURPHY AS PRESIDENT AND CEO.
* QTRLY LOSS PER SHARE $0.10
* QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nCNWpPt63a
Further company coverage: CHH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareRx
See all newsCanada's CareRx Q2 revenue rises, slightly misses estimates
Canada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates